News Detail

DURHAM, N.C.; 3 NOV 2023: Using a technique that has shown promise in targeting cancer tumors, a Duke Health team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.
Tested in cell cultures using the Bor......
View Details
Source : Duke Health
Ph.D.
Lyme
Borrelia
Duke Health
Timothy Haystead
Haystead
Duke's Department of Pharmacology and Cancer Biology
Related News
- Researchers develop a better way to deliver long-lasting drugs (25-03-2025)
- Pioneer groundbreaking light-driven method to create key drug compounds (24-03-2025)
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- IIT Roorkee researchers identify a potential drug against Chikungunya (18-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)